{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,2,21]],"date-time":"2025-02-21T11:10:23Z","timestamp":1740136223840,"version":"3.37.3"},"reference-count":43,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2020,11,25]],"date-time":"2020-11-25T00:00:00Z","timestamp":1606262400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"},{"start":{"date-parts":[[2020,11,25]],"date-time":"2020-11-25T00:00:00Z","timestamp":1606262400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100000865","name":"Bill and Melinda Gates Foundation","doi-asserted-by":"publisher","award":["OPP46099"],"award-info":[{"award-number":["OPP46099"]}],"id":[{"id":"10.13039\/100000865","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Malar J"],"published-print":{"date-parts":[[2020,12]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n<jats:title>Background<\/jats:title>\n<jats:p>Intermittent preventive treatment in pregnancy (IPTp) with sulfadoxine-pyrimethamine (SP) is recommended for preventing malaria in pregnancy in areas of moderate-to-high transmission in sub-Saharan Africa. However, due to increasing parasite resistance to SP, research on alternative strategies is a priority. The study assessed the implementation feasibility of intermittent screening and treatment (ISTp) in the second and third trimester at antenatal care (ANC) with malaria rapid diagnostic tests (RDTs) and treatment of positive cases with dihydroartemisinin-piperaquine (DP) compared to IPTp-SP in western Kenya.<\/jats:p>\n<\/jats:sec><jats:sec>\n<jats:title>Methods<\/jats:title>\n<jats:p>A 10-month implementation study was conducted in 12 government health facilities in four sub-counties. Six health facilities were assigned to either ISTp-DP or IPTp-SP. Evaluation comprised of facility audits, ANC observations, and exit interviews. Intermediate and cumulative effectiveness analyses were performed on all processes involved in delivery of ISTp-DP including RDT proficiency and IPTp-SP\u2009\u00b1\u2009directly observed therapy (DOT, standard of care). Logistic regression was used to identify predictors of receiving each intervention.<\/jats:p>\n<\/jats:sec><jats:sec>\n<jats:title>Results<\/jats:title>\n<jats:p>A total of 388 and 389 women were recruited in the ISTp-DP and IPTp-SP arms, respectively. For ISTp-DP, 90% (289\/320) of eligible women received an RDT. Of 11% (32\/289) who tested positive, 71% received the correct dose of DP and 31% the first dose by DOT, and only 6% were counselled on subsequent doses. Women making a sick visit and being tested in a facility with a resident microscopist were more likely to receive ISTp-DP (AOR 1.78, 95% CI 1.31, 2.41; and AOR 3.75, 95% CI 1.31, 2.40, respectively). For IPTp-SP, only 57% received a dose of SP by DOT. Payment for a laboratory test was independently associated with receipt of SP by DOT (AOR 6.43, 95% CI 2.07, 19.98).<\/jats:p>\n<\/jats:sec><jats:sec>\n<jats:title>Conclusions<\/jats:title>\n<jats:p>The findings indicate that the systems effectiveness of ANC clinics to deliver ISTp-DP under routine conditions was poor in comparison to IPTp-SP. Several challenges to integration of ISTp with ANC were identified that may need to be considered by countries that have introduced screening at first ANC visit and, potentially, for future adoption of ISTp with more sensitive RDTs. Understanding the effectiveness of ISTp-DP will require additional research on pregnant women\u2019s adherence to ACT.<\/jats:p>\n<\/jats:sec>","DOI":"10.1186\/s12936-020-03505-0","type":"journal-article","created":{"date-parts":[[2020,11,25]],"date-time":"2020-11-25T13:03:07Z","timestamp":1606309387000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":7,"title":["Intermittent screening and treatment with dihydroartemisinin-piperaquine for the prevention of malaria in pregnancy: implementation feasibility in a routine healthcare system setting in western Kenya"],"prefix":"10.1186","volume":"19","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-1588-485X","authenticated-orcid":false,"given":"Jenny","family":"Hill","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Peter","family":"Ouma","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Seth","family":"Oluoch","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jane","family":"Bruce","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Simon","family":"Kariuki","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Meghna","family":"Desai","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jayne","family":"Webster","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2020,11,25]]},"reference":[{"issue":"1\u20132 Suppl","key":"3505_CR1","doi-asserted-by":"publisher","first-page":"28","DOI":"10.4269\/ajtmh.2001.64.28","volume":"64","author":"RW Steketee","year":"2001","unstructured":"Steketee RW, Nahlen BL, Parise ME, Menendez C. The burden of malaria in pregnancy in malaria-endemic areas. Am J Trop Med Hyg. 2001;64(1\u20132 Suppl):28\u201335.","journal-title":"Am J Trop Med Hyg"},{"key":"3505_CR2","doi-asserted-by":"publisher","first-page":"e107","DOI":"10.1016\/S1473-3099(18)30066-5","volume":"18","author":"SJ Rogerson","year":"2018","unstructured":"Rogerson SJ, Desai M, Mayor A, Sicuri E, Taylor SM, van Eijk AM. Burden, pathology, and costs of malaria in pregnancy: new developments for an old problem. Lancet Infect Dis. 2018;18:e107\u201318.","journal-title":"Lancet Infect Dis"},{"key":"3505_CR3","doi-asserted-by":"publisher","first-page":"e1000221","DOI":"10.1371\/journal.pmed.1000221","volume":"7","author":"S Dellicour","year":"2010","unstructured":"Dellicour S, Tatem AJ, Guerra CA, Snow RW, ter Kuile FO. Quantifying the number of pregnancies at risk of malaria in 2007: a demographic study. PLoS Med. 2010;7:e1000221.","journal-title":"PLoS Med"},{"key":"3505_CR4","unstructured":"WHO. A strategic framework for malaria prevention and control during pregnancy in the Africa region. Brazzaville, World Health Organization Regional Office for Africa. 2004;AFR\/MAL\/04\/01."},{"key":"3505_CR5","doi-asserted-by":"publisher","first-page":"323","DOI":"10.1093\/cid\/civ881","volume":"62","author":"M Desai","year":"2016","unstructured":"Desai M, Gutman J, Taylor SM, Wiegand RE, Khairallah C, Kayentao K, et al. Impact of sulfadoxine-pyrimethamine resistance on effectiveness of intermittent preventive therapy for malaria in pregnancy at clearing infections and preventing low birth weight. Clin Infect Dis. 2016;62:323\u201333.","journal-title":"Clin Infect Dis"},{"key":"3505_CR6","doi-asserted-by":"publisher","first-page":"1997","DOI":"10.1093\/infdis\/jiu836","volume":"211","author":"J Gutman","year":"2015","unstructured":"Gutman J, Kalilani L, Taylor S, Zhou Z, Wiegand RE, Thwai KL, et al. The A581G mutation in the gene encoding Plasmodium falciparum dihydropteroate synthetase reduces the effectiveness of sulfadoxine-pyrimethamine preventive therapy in Malawian pregnant women. J Infect Dis. 2015;211:1997\u20132005.","journal-title":"J Infect Dis"},{"key":"3505_CR7","doi-asserted-by":"publisher","first-page":"e16090","DOI":"10.7554\/eLife.16090","volume":"5","author":"TS Churcher","year":"2016","unstructured":"Churcher TS, Lissenden N, Griffin JT, Worrall E, Ranson H. The impact of pyrethroid resistance on the efficacy and effectiveness of bednets for malaria control in Africa. Elife. 2016;5:e16090.","journal-title":"Elife"},{"key":"3505_CR8","doi-asserted-by":"publisher","first-page":"e119","DOI":"10.1016\/S1473-3099(18)30064-1","volume":"18","author":"M Desai","year":"2018","unstructured":"Desai M, Hill J, Fernandes S, Walker P, Pell C, Gutman J, et al. Prevention of malaria in pregnancy. Lancet Infect Dis. 2018;18:e119\u201332.","journal-title":"Lancet Infect Dis"},{"key":"3505_CR9","doi-asserted-by":"publisher","first-page":"1202","DOI":"10.1086\/591944","volume":"198","author":"CA Clerk","year":"2008","unstructured":"Clerk CA, Bruce J, Affipunguh PK, Mensah N, Hodgson A, Greenwood B, et al. A randomized, controlled trial of intermittent preventive treatment with sulfadoxine-pyrimethamine, amodiaquine, or the combination in pregnant women in Ghana. J Infect Dis. 2008;198:1202\u201311.","journal-title":"J Infect Dis"},{"key":"3505_CR10","doi-asserted-by":"publisher","first-page":"e1001733","DOI":"10.1371\/journal.pmed.1001733","volume":"11","author":"R Gonzalez","year":"2014","unstructured":"Gonzalez R, Mombo-Ngoma G, Ouedraogo S, Kakolwa MA, Abdulla S, Accrombessi M, et al. Intermittent preventive treatment of malaria in pregnancy with mefloquine in HIV-negative women: a multicentre randomized controlled trial. PLoS Med. 2014;11:e1001733.","journal-title":"PLoS Med"},{"key":"3505_CR11","doi-asserted-by":"publisher","first-page":"e1001735","DOI":"10.1371\/journal.pmed.1001735","volume":"11","author":"R Gonzalez","year":"2014","unstructured":"Gonzalez R, Desai M, Macete E, Ouma P, Kakolwa MA, Abdulla S, et al. Intermittent preventive treatment of malaria in pregnancy with mefloquine in HIV-infected women receiving cotrimoxazole prophylaxis: a multicenter randomized placebo-controlled trial. PLoS Med. 2014;11:e1001735.","journal-title":"PLoS Med"},{"key":"3505_CR12","doi-asserted-by":"publisher","first-page":"e0157045","DOI":"10.1371\/journal.pone.0157045","volume":"11","author":"J Kimani","year":"2016","unstructured":"Kimani J, Phiri K, Kamiza S, Duparc S, Ayoub A, Rojo R, et al. Efficacy and safety of azithromycin-chloroquine versus sulfadoxine-pyrimethamine for intermittent preventive treatment of Plasmodium falciparum malaria infection in pregnant women in Africa: an open-label, randomized trial. PLoS ONE. 2016;11:e0157045.","journal-title":"PLoS ONE"},{"key":"3505_CR13","doi-asserted-by":"publisher","first-page":"e1002124","DOI":"10.1371\/journal.pmed.1002124","volume":"13","author":"M Madanitsa","year":"2016","unstructured":"Madanitsa M, Kalilani L, Mwapasa V, van Eijk AM, Khairallah C, Ali D, et al. Scheduled intermittent screening with rapid diagnostic tests and treatment with dihydroartemisinin-piperaquine versus intermittent preventive therapy with sulfadoxine-pyrimethamine for malaria in pregnancy in Malawi: an open-label randomized controlled trial. PLoS Med. 2016;13:e1002124.","journal-title":"PLoS Med"},{"key":"3505_CR14","doi-asserted-by":"publisher","first-page":"e0132247","DOI":"10.1371\/journal.pone.0132247","volume":"10","author":"H Tagbor","year":"2015","unstructured":"Tagbor H, Cairns M, Bojang K, Coulibaly SO, Kayentao K, Williams J, et al. A non-inferiority, individually randomized trial of intermittent screening and treatment versus intermittent preventive treatment in the control of malaria in pregnancy. PLoS ONE. 2015;10:e0132247.","journal-title":"PLoS ONE"},{"key":"3505_CR15","doi-asserted-by":"publisher","first-page":"2507","DOI":"10.1016\/S0140-6736(15)00310-4","volume":"386","author":"M Desai","year":"2015","unstructured":"Desai M, Gutman J, L\u2019Lanziva A, Otieno K, Juma E, Kariuki S, et al. Intermittent screening and treatment or intermittent preventive treatment with dihydroartemisinin-piperaquine versus intermittent preventive treatment with sulfadoxine-pyrimethamine for the control of malaria during pregnancy in western Kenya: an open-label, three-group, randomised controlled superiority trial. Lancet. 2015;386:2507\u201319.","journal-title":"Lancet"},{"key":"3505_CR16","doi-asserted-by":"publisher","first-page":"e14425","DOI":"10.1371\/journal.pone.0014425","volume":"5","author":"H Tagbor","year":"2010","unstructured":"Tagbor H, Bruce J, Agbo M, Greenwood B, Chandramohan D. Intermittent screening and treatment versus intermittent preventive treatment of malaria in pregnancy: a randomised controlled non-inferiority trial. PLoS ONE. 2010;5:e14425.","journal-title":"PLoS ONE"},{"key":"3505_CR17","doi-asserted-by":"publisher","first-page":"1428","DOI":"10.1016\/S0140-6736(18)32224-4","volume":"393","author":"R Kajubi","year":"2019","unstructured":"Kajubi R, Ochieng T, Kakuru A, Jagannathan P, Nakalembe M, Ruel T, et al. Monthly sulfadoxine-pyrimethamine versus dihydroartemisinin-piperaquine for intermittent preventive treatment of malaria in pregnancy: a double-blind, randomised, controlled, superiority trial. Lancet. 2019;393:1428\u201339.","journal-title":"Lancet"},{"key":"3505_CR18","doi-asserted-by":"publisher","first-page":"928","DOI":"10.1056\/NEJMoa1509150","volume":"374","author":"A Kakuru","year":"2016","unstructured":"Kakuru A, Jagannathan P, Muhindo MK, Natureeba P, Awori P, Nakalembe M, et al. Dihydroartemisinin-piperaquine for the prevention of malaria in pregnancy. N Engl J Med. 2016;374:928\u201339.","journal-title":"N Engl J Med"},{"key":"3505_CR19","doi-asserted-by":"publisher","first-page":"e0150259","DOI":"10.1371\/journal.pone.0150259","volume":"11","author":"J Hill","year":"2016","unstructured":"Hill J, Hoyt J, Achieng F, Ouma P, L\u2019Lanziva A, Kariuki S, et al. User and provider acceptability of intermittent screening and treatment and intermittent preventive treatment with dihydroartemisinin-piperaquine to prevent malaria in pregnancy in Western Kenya. PLoS ONE. 2016;11:e0150259.","journal-title":"PLoS ONE"},{"key":"3505_CR20","doi-asserted-by":"publisher","first-page":"18","DOI":"10.1186\/1475-2875-9-18","volume":"9","author":"LA Smith","year":"2010","unstructured":"Smith LA, Jones C, Adjei RO, Antwi GD, Afrah NA, Greenwood B, et al. Intermittent screening and treatment versus intermittent preventive treatment of malaria in pregnancy: user acceptability. Malar J. 2010;9:18.","journal-title":"Malar J"},{"key":"3505_CR21","doi-asserted-by":"publisher","first-page":"574","DOI":"10.1186\/s12936-016-1627-5","volume":"15","author":"D Almond","year":"2016","unstructured":"Almond D, Madanitsa M, Mwapasa V, Kalilani-Phiri L, Webster J, Ter Kuile F, et al. Provider and user acceptability of intermittent screening and treatment for the control of malaria in pregnancy in Malawi. Malar J. 2016;15:574.","journal-title":"Malar J"},{"key":"3505_CR22","doi-asserted-by":"publisher","first-page":"e24035","DOI":"10.1371\/journal.pone.0024035","volume":"6","author":"L Smith Paintain","year":"2011","unstructured":"Smith Paintain L, Antwi GD, Jones C, Amoako E, Adjei RO, Afrah NA, et al. Intermittent screening and treatment versus intermittent preventive treatment of malaria in pregnancy: provider knowledge and acceptability. PLoS ONE. 2011;6:e24035.","journal-title":"PLoS ONE"},{"key":"3505_CR23","doi-asserted-by":"publisher","first-page":"341","DOI":"10.1186\/s12936-018-2490-3","volume":"17","author":"J Hoyt","year":"2018","unstructured":"Hoyt J, Landuwulang CUR, Ansariadi, Ahmed R, Burdam FH, Bonsapia I, Poespoprodjo JR, et al. Intermittent screening and treatment or intermittent preventive treatment compared to current policy of single screening and treatment for the prevention of malaria in pregnancy in Eastern Indonesia: acceptability among health providers and pregnant women. Malar J. 2018;17:341.","journal-title":"Malar J."},{"key":"3505_CR24","doi-asserted-by":"publisher","first-page":"452","DOI":"10.1016\/j.amepre.2009.02.002","volume":"36","author":"DJ Bowen","year":"2009","unstructured":"Bowen DJ, Kreuter M, Spring B, Cofta-Woerpel L, Linnan L, Weiner D, et al. How we design feasibility studies. Am J Prev Med. 2009;36:452\u20137.","journal-title":"Am J Prev Med"},{"key":"3505_CR25","unstructured":"Ministry of Public Health and Sanitation Division of Malaria Control. National Malaria Policy. Nairobi, Republic of Kenya, 2010."},{"key":"3505_CR26","doi-asserted-by":"publisher","first-page":"e67520","DOI":"10.1371\/journal.pone.0067520","volume":"8","author":"J Webster","year":"2013","unstructured":"Webster J, Kayentao K, Bruce J, Diawara SI, Abathina A, Haiballa AA, et al. Prevention of malaria in pregnancy with intermittent preventive treatment and insecticide treated nets in Mali: a quantitative health systems effectiveness analysis. PLoS ONE. 2013;8:e67520.","journal-title":"PLoS ONE"},{"key":"3505_CR27","doi-asserted-by":"publisher","first-page":"459","DOI":"10.1093\/heapol\/czl029","volume":"21","author":"S Vyas","year":"2006","unstructured":"Vyas S, Kumaranayake L. Constructing socio-economic status indices: how to use principal components analysis. Health Policy Plan. 2006;21:459\u201368.","journal-title":"Health Policy Plan"},{"key":"3505_CR28","unstructured":"Bosman DA, Cunningham J, Lindblade KA, Noor A. WHO Technical Consultation on research requirements to support policy recommendations on highly sensitive malaria diagnostics. http:\/\/www.whoint\/malaria\/mpac\/mpac-april2018-hi-sensitive-tests-session5pdf. 2018."},{"key":"3505_CR29","doi-asserted-by":"publisher","first-page":"190","DOI":"10.1016\/S1473-3099(10)70295-4","volume":"11","author":"AM van Eijk","year":"2011","unstructured":"van Eijk AM, Hill J, Alegana VA, Kirui V, Gething PW, ter Kuile FO, et al. Coverage of malaria protection in pregnant women in sub-Saharan Africa: a synthesis and analysis of national survey data. Lancet Infect Dis. 2011;11:190\u2013207.","journal-title":"Lancet Infect Dis"},{"key":"3505_CR30","doi-asserted-by":"publisher","first-page":"221","DOI":"10.1186\/s12936-016-1261-2","volume":"15","author":"S Dellicour","year":"2016","unstructured":"Dellicour S, Hill J, Bruce J, Ouma P, Marwanga D, Otieno P, et al. Effectiveness of the delivery of interventions to prevent malaria in pregnancy in Kenya. Malar J. 2016;15:221.","journal-title":"Malar J"},{"key":"3505_CR31","doi-asserted-by":"publisher","first-page":"e1163","DOI":"10.1016\/S2214-109X(18)30398-X","volume":"6","author":"AK Rowe","year":"2018","unstructured":"Rowe AK, Rowe SY, Peters DH, Holloway KA, Chalker J, Ross-Degnan D. Effectiveness of strategies to improve health-care provider practices in low-income and middle-income countries: a systematic review. Lancet Glob Health. 2018;6:e1163\u201375.","journal-title":"Lancet Glob Health"},{"key":"3505_CR32","volume-title":"Guidelines for the treatment of malaria","author":"WHO","year":"2015","unstructured":"WHO. Guidelines for the treatment of malaria. 3rd ed. Geneva: World Health Organization; 2015.","edition":"3"},{"key":"3505_CR33","doi-asserted-by":"publisher","first-page":"1515","DOI":"10.1111\/j.1365-3156.2007.01960.x","volume":"12","author":"P Ouma","year":"2007","unstructured":"Ouma P, van Eijk AM, Hamel MJ, Parise M, Ayisi JG, Otieno K, et al. Malaria and anaemia among pregnant women at first antenatal clinic visit in Kisumu, western Kenya. Trop Med Int Health. 2007;12:1515\u201323.","journal-title":"Trop Med Int Health"},{"key":"3505_CR34","doi-asserted-by":"publisher","first-page":"427","DOI":"10.1186\/1475-2875-12-427","volume":"12","author":"C Pell","year":"2013","unstructured":"Pell C, Menaca A, Afrah NA, Manda-Taylor L, Chatio S, Were F, et al. Prevention and management of malaria during pregnancy: findings from a comparative qualitative study in Ghana, Kenya and Malawi. Malar J. 2013;12:427.","journal-title":"Malar J"},{"key":"3505_CR35","doi-asserted-by":"publisher","first-page":"e65437","DOI":"10.1371\/journal.pone.0065437","volume":"8","author":"J Webster","year":"2013","unstructured":"Webster J, Kayentao K, Diarra S, Diawara SI, Haiballa AA, Doumbo OK, et al. A qualitative health systems effectiveness analysis of the prevention of malaria in pregnancy with intermittent preventive treatment and insecticide treated nets in Mali. PLoS ONE. 2013;8:e65437.","journal-title":"PLoS ONE"},{"key":"3505_CR36","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1186\/1475-2875-13-7","volume":"13","author":"K Banek","year":"2014","unstructured":"Banek K, Lalani M, Staedke SG, Chandramohan D. Adherence to artemisinin-based combination therapy for the treatment of malaria: a systematic review of the evidence. Malar J. 2014;13:7.","journal-title":"Malar J"},{"key":"3505_CR37","doi-asserted-by":"publisher","first-page":"e1695","DOI":"10.1016\/S2214-109X(19)30405-X","volume":"7","author":"C Kitojo","year":"2019","unstructured":"Kitojo C, Gutman JR, Chacky F, Kigadye E, Mkude S, Mandike R, et al. Estimating malaria burden among pregnant women using data from antenatal care centres in Tanzania: a population-based study. Lancet Glob Health. 2019;7:e1695\u2013705.","journal-title":"Lancet Glob Health"},{"key":"3505_CR38","doi-asserted-by":"publisher","first-page":"3799","DOI":"10.1038\/s41467-020-17528-3","volume":"11","author":"PGT Walker","year":"2020","unstructured":"Walker PGT, Cairns M, Slater H, Gutman J, Kayentao K, Williams JE, et al. Modelling the incremental benefit of introducing malaria screening strategies to antenatal care in Africa. Nat Commun. 2020;11:3799.","journal-title":"Nat Commun"},{"key":"3505_CR39","doi-asserted-by":"publisher","first-page":"e0198784","DOI":"10.1371\/journal.pone.0198784","volume":"13","author":"N Young","year":"2018","unstructured":"Young N, Taegtmeyer M, Aol G, Bigogo GM, Phillips-Howard PA, Hill J, et al. Integrated point-of-care testing (POCT) of HIV, syphilis, malaria and anaemia in antenatal clinics in western Kenya: a longitudinal implementation study. PLoS ONE. 2018;13:e0198784.","journal-title":"PLoS ONE"},{"key":"3505_CR40","doi-asserted-by":"publisher","first-page":"74","DOI":"10.1186\/s12913-018-3844-9","volume":"19","author":"N Young","year":"2019","unstructured":"Young N, Achieng F, Desai M, Phillips-Howard P, Hill J, Aol G, et al. Integrated point-of-care testing (POCT) for HIV, syphilis, malaria and anaemia at antenatal facilities in western Kenya: a qualitative study exploring end-users\u2019 perspectives of appropriateness, acceptability and feasibility. BMC Health Serv Res. 2019;19:74.","journal-title":"BMC Health Serv Res"},{"key":"3505_CR41","doi-asserted-by":"publisher","first-page":"299","DOI":"10.1093\/intqhc\/mzl009","volume":"18","author":"SY Rowe","year":"2006","unstructured":"Rowe SY, Olewe MA, Kleinbaum DG, McGowan JE Jr, McFarland DA, et al. The influence of observation and setting on community health workers\u2019 practices. Int J Qual Health Care. 2006;18:299\u2013305.","journal-title":"Int J Qual Health Care"},{"key":"3505_CR42","doi-asserted-by":"publisher","first-page":"2330","DOI":"10.1016\/j.socscimed.2006.06.003","volume":"63","author":"K Leonard","year":"2006","unstructured":"Leonard K, Masatu MC. Outpatient process quality evaluation and the Hawthorne Effect. Soc Sci Med. 2006;63:2330\u201340.","journal-title":"Soc Sci Med"},{"key":"3505_CR43","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1186\/1471-2393-10-35","volume":"10","author":"AB Pembe","year":"2010","unstructured":"Pembe AB, Carlstedt A, Urassa DP, Lindmark G, Nystrom L, et al. Quality of antenatal care in rural Tanzania: counselling on pregnancy danger signs. BMC Pregnancy Childbirth. 2010;10:35.","journal-title":"BMC Pregnancy Childbirth"}],"container-title":["Malaria Journal"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12936-020-03505-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/s12936-020-03505-0\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12936-020-03505-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,11,25]],"date-time":"2020-11-25T13:46:59Z","timestamp":1606312019000},"score":1,"resource":{"primary":{"URL":"https:\/\/malariajournal.biomedcentral.com\/articles\/10.1186\/s12936-020-03505-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,11,25]]},"references-count":43,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2020,12]]}},"alternative-id":["3505"],"URL":"https:\/\/doi.org\/10.1186\/s12936-020-03505-0","relation":{},"ISSN":["1475-2875"],"issn-type":[{"type":"electronic","value":"1475-2875"}],"subject":[],"published":{"date-parts":[[2020,11,25]]},"assertion":[{"value":"2 July 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 November 2020","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 November 2020","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors have no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"433"}}